Unknown

Dataset Information

0

Sofosbuvir Add-on to Ribavirin Treatment for Chronic Hepatitis E Virus Infection in Solid Organ Transplant Recipients Does Not Result in Sustained Virological Response.


ABSTRACT: Ribavirin is effective for treating immunocompromised patients with chronic hepatitis E virus infection. However, ribavirin treatment is not always successful. We describe 3 solid organ transplant recipients treated with sofosbuvir and ribavirin after failing ribavirin monotherapy. Complete elimination of hepatitis E virus could not be achieved.

SUBMITTER: van Wezel EM 

PROVIDER: S-EPMC6690733 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Sofosbuvir Add-on to Ribavirin Treatment for Chronic Hepatitis E Virus Infection in Solid Organ Transplant Recipients Does Not Result in Sustained Virological Response.

van Wezel E M EM   de Bruijne J J   Damman K K   Bijmolen M M   van den Berg A P AP   Verschuuren E A M EAM   Ruigrok G A GA   Riezebos-Brilman A A   Knoester M M  

Open forum infectious diseases 20190801 8


Ribavirin is effective for treating immunocompromised patients with chronic hepatitis E virus infection. However, ribavirin treatment is not always successful. We describe 3 solid organ transplant recipients treated with sofosbuvir and ribavirin after failing ribavirin monotherapy. Complete elimination of hepatitis E virus could not be achieved. ...[more]

Similar Datasets

| S-EPMC4261198 | biostudies-other
| S-EPMC5636643 | biostudies-literature
| S-EPMC7850530 | biostudies-literature
| S-EPMC4402344 | biostudies-literature
| S-EPMC5324811 | biostudies-literature
| S-EPMC7453406 | biostudies-literature
| S-EPMC6669701 | biostudies-literature
| S-EPMC4769648 | biostudies-literature
| S-EPMC3358074 | biostudies-literature